Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See why I upgrade my rating on MO to buy.

Discover why Altria may be a strong investment opportunity, with potential for significant total returns and a possible credit rating upgrade. Explore more here.

Altria Group Inc (MO) stock saw a modest uptick, ending the day at $51.16 which represents a slight increase of $0.12 or 0.24% from the prior close of $51.04. The stock opened at $50.9 and touched a low of $50.

The latest trading session saw Altria (MO) ending at $51.86, denoting a +1.37% adjustment from its last day's close. This move outpaced the S&P 500's daily gain of 1%. On the other hand, the Dow registered a gain of 0.

Morgan Stanley began coverage on shares of Altria Group (NYSE:MO – Free Report) in a research note issued to investors on Thursday morning, Marketbeat Ratings reports. The brokerage issued an equal weight rating and a $54.

Altria Group Inc. (NYSE: MO) is rewarding its shareholders once again with a quarterly dividend of $1.02, payable on Friday, Jan. 10. That is the same as in the prior payout. The company admitted recently that one its most high-profile brands has seen waning demand,

During the webcast, Billy Gifford, Altria’s Chief Executive Officer, and Sal Mancuso, Altria’s Chief Financial Officer, will discuss the Company’s 2024 fourth-quarter and full-year business results and answer questions from the investment community and news media.

In the closing of the recent trading day, Altria (MO) stood at $51.04, denoting a -0.62% change from the preceding trading day.

In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Morgan Stanley initiated coverage of Altria Group (MO) with an Equal Weight rating and $54 price target The firm sees a balanced risk/reward

Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this move aligns with its long-term strategy.